Clinical Trials Logo
  1. Home
  2. Uremia
  3. NCT06233838

Multi-center Clinical Study on Hemoperfusion of KHA80

Uremia Clinical Trial

Official title:
Prospective, Multicenter, Randomized, Open Label Study on the Efficacy and Safety of Comparison of KHA80 Blood Perfusion Combined With Hemodialysis and Conventional Hemodialysis in Clearing IL-6, β2-MG and PTH in Maintenance Hemodialysis Patients

Clinical Trial Summary

To evaluate the decreasing rate of blood IL-6, β2-MG and PTH in maintenance hemodialysis patients in the 52nd week compared with routine hemodialysis.

Clinical Trial Description

394 patients with maintenance hemodialysis were included in the study, and the blood purification time was ≥8 hours per week (including routine hemodialysis, high-throughput hemodialysis, hemodialysis filtration, hemoperfusion, etc.). Randomly assign the control group (197 cases) to receive hemodialysis or hemodialysis filtration treatment, and the frequency of treatment is ≥2 times/week; The experimental group (197 cases) were randomly assigned to receive Jianfan KHA80 hemoperfusion treatment on the basis of hemodialysis or hemodiafiltration treatment, and the frequency of hemoperfusion treatment was ≥2 times/month. The follow-up data of 0, 4, 12, 24, 36 and 52 weeks of treatment in the two groups were collected, and the information of combined medication and adverse events was also collected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06233838
Study type Interventional
Source First Affiliated Hospital of Fujian Medical University
Contact
Status Not yet recruiting
Phase N/A
Start date February 1, 2024
Completion date February 28, 2025
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT00577967 - Gabapentin - A Solution to Uremic Pruritus? N/A
Completed NCT01583309 - Effects of Convective Therapies in Dialysis Patients Phase 3
Completed NCT03437538 - Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter N/A
Completed NCT00649298 - A Clinical Trial of IntensiVE Dialysis Phase 4
Completed NCT05750875 - Gabapentin Versus Loratadine in Uremic Pruritus Phase 4
Recruiting NCT01408797 - Clonal Deletion on Living-Relative Donor Kidney Transplantation Phase 1/Phase 2
Completed NCT01267760 - Clinical and Biochemical Effects of Multipass Hemodialysis Phase 2
Recruiting NCT00375635 - Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis N/A
Recruiting NCT05076318 - Dysregulated Urea-synthesis at Terminal Uremia N/A
Completed NCT05899283 - A Comparative Study of Two Kinds of Hemodialysis Filters N/A
Completed NCT04768309 - Impact of Intestinal Microbiota on Uremic Toxins Productions N/A
Not yet recruiting NCT05386433 - Paxlovid in the Treatment of COVID-19 Patients With Uremia Early Phase 1
Completed NCT01391884 - Elimination of Incretin Hormones in Patients With Severe Kidney Failure N/A
Completed NCT00442819 - Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial Kidney Phase 4
Not yet recruiting NCT02266238 - Stenosis of Arteria-Venous Fistula in Maintenance Hemodialysis Patients: Early Intervention Trial N/A
Recruiting NCT01766895 - Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan
Completed NCT00388648 - Very Low Protein Diet or Dialysis in Uremic Elderly? Phase 4
Withdrawn NCT03416192 - 12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter. N/A
Recruiting NCT02446535 - Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW? N/A
Recruiting NCT02606955 - Probing the Dry Weight by Bioimpedance: The Resistance Stabilization Test N/A